AVANIR Pharmaceuticals (AMEX: AVN) signed global research, development and commercialization agreement with Novartis (NYSE: NVS) to develop orally active small ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE